Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell...

Area of Science:

• Endocrinology
• Metabolic Research
• Cell Biology

Background:

• Adiponectin is an adipokine with insulin-sensitizing, antiatherogenic, and anti-inflammatory properties.
• Adiponectin receptors (AdipoR1 and AdipoR2) mediate adiponectin's effects and are expressed in various tissues.
• The role of adiponectin in human insulin secretion and beta-cell apoptosis remains under investigation.

Purpose of the Study:

• To investigate the expression of adiponectin receptors in human islets.
• To determine the effect of adiponectin on glucose-stimulated insulin secretion and fatty acid-induced beta-cell apoptosis in human islets.
• To assess the association between plasma adiponectin levels and in vivo insulin secretory function in humans.

Main Methods:

• Human islets from multiorgan donors were used to examine AdipoR1 and AdipoR2 expression at mRNA and protein levels.
• Insulin secretion was measured using RIA, and beta-cell apoptosis was assessed via TUNEL assay and flow cytometry.
• In vivo insulin secretion was evaluated in normal glucose-tolerant subjects using hyperglycemic clamps.

Main Results:

• Adiponectin receptors (AdipoR1 and AdipoR2) are expressed in human islets.
• Adiponectin did not alter basal or glucose-stimulated insulin secretion or basal/fatty acid-induced beta-cell apoptosis.
• Fasting plasma adiponectin concentrations showed no association with glucose-stimulated, GLP-1-stimulated, or arginine-stimulated insulin secretion.

Conclusions:

• Adiponectin receptors are present in human islets, suggesting a potential regulatory role.
• Adiponectin does not appear to directly influence insulin secretion or beta-cell apoptosis in humans.
• These findings clarify the specific actions of adiponectin within human pancreatic beta-cells.